Volume 26, Number 11—November 2020
Research
Systematic Review and Meta-Analyses of Incidence for Group B Streptococcus Disease in Infants and Antimicrobial Resistance, China
Yijun Ding, Yajuan Wang
, Yingfen Hsia, Neal Russell, and Paul T. Heath
, Yingfen Hsia, Neal Russell, and Paul T. Heath
Table 2
Proportion of isolates demonstrating antimicrobial resistance in systematic review and meta-analyses of incidence of group B Streptococcus disease in infants, China*
| Reference |
Publication year |
No. isolates |
PEN |
AMP |
CFZ |
CAX |
VAN |
LZD |
CHL |
ERY |
TET |
CIP |
MXF |
LVX |
NIT |
TGC |
| Zeng et al. | 2013 | 11 | 0 | 0 | NT | NT | 0 | 0 | NT | NT | 100.0 | 9.1 | 9.1 | 9.1 | 0 | 0 |
| Luo et al. | 2013 | 15 | 0 | 0 | NT | 0 | 0 | NT | NT | 86.7 | NT | NT | NT | 0 | NT | NT |
| Zheng et al. | 2014 | 12 | 0 | 0 | NT | NT | 0 | NT | NT | 16.7 | 66.7 | NT | NT | NT | NT | NT |
| Chen et al. | 2014 | 16 | 0 | 0 | NT | 0 | 0 | NT | NT | 62.5 | NT | 25.0 | NT | 18.8 | NT | NT |
| Zhu et al. | 2014 | 13 | 0 | 10.0 | 0 | 100.0 | 38.5 | 0 | 100.0 | 100.0 | NT | 33.3 | NT | 8.3 | 0 | NT |
| Fan et al. | 2014 | 42 | 0 | 0 | NT | NT | 0 | 0 | NT | 69.1 | 73.8 | NT | NT | 38.1 | NT | 0 |
| Wang et al. | 2015 | 15 | 0 | 20.0 | 40.0 | 80.0 | 0 | 0 | 86.7 | 100.0 | NT | 26.7 | NT | 20.0 | 0 | NT |
| Zhang et al. | 2015 | 6 | 0 | 0 | 83.3 | NT | 0 | 0 | NT | NT | NT | NT | NT | NT | NT | NT |
| Lei et al. | 2015 | 20 | NT | 0 | NT | NT | 0 | 0 | 25.0 | 75.0 | NT | 80.0 | NT | 70.0 | 0 | NT |
| Zhang et al. | 2015 | 45 | 0 | 2.2 | NT | NT | 0 | 0 | NT | 42.2 | 93.3 | 0 | 0 | 0 | NT | 0 |
| Cai et al. | 2016 | 15 | 0 | 0 | NT | NT | 0 | 0 | NT | 46.7 | 100.0 | NT | 6.7 | 6.7 | 13.3 | 0 |
| Zhao | 2016 | 28 | 0 | 0 | NT | 0 | 0 | 3.6 | NT | 67.9 | NT | NT | NT | 42.9 | NT | NT |
| Huang et al. | 2016 | 49 | NT | NT | NT | NT | NT | NT | NT | 63.3 | 98.0 | 11.9 | 12.2 | 7.7 | NT | NT |
| Liu et al. | 2017 | 15 | 0 | NT | NT | NT | 0 | NT | NT | NT | NT | NT | NT | NT | NT | NT |
| Zhang et al. | 2017 | 55 | 0 | 0 | NT | NT | 0 | 0 | NT | 56.6 | 98.1 | 1.9 | NT | NT | NT | NT |
| Zhang et al. | 2017 | 15 | 6.7 | 0 | NT | NT | 0 | 0 | NT | NT | 80.0 | 73.3 | 73.3 | 60.0 | 0 | 0 |
| Tan et al. | 2017 | 20 | 0 | 0 | NT | NT | 0 | 0 | NT | NT | 100.0 | 16.7 | NT | 16.7 | NT | 0 |
| Zhou et al. | 2017 | 84 | 4.8 | 2.4 | 2.4 | 0 | 0 | 0 | 4.8 | 72.6 | 100.0 | 35.2 | NT | 36.9 | 0 | NT |
| Zhao | 2017 | 45 | 0 | NT | NT | 0 | 0 | 2.2 | NT | 64.4 | NT | NT | NT | 42.2 | NT | NT |
| Guan et al. | 2018 | 68 | 0 | NT | NT | 0 | 0 | 0 | NT | 57.4 | 95.6 | NT | NT | 5.9 | NT | NT |
| Median | NA | NA | 0 | 0 | 21.2 | 0 | 0 | 0 | 55.8 | 64.4 | 98.0 | 25.0 | 9.1 | 17.7 | 0 | 0 |
| IQI 25% | NA | NA | 0 | 0 | 0.6 | 0 | 0 | 0 | 9.8 | 56.6 | 80.0 | 9.1 | 3.3 | 6.9 | 0 | 0 |
| IQI 75% | NA | NA | 0 | 1.7 | 72.5 | 60.0 | 0 | 0 | 96.7 | 75.0 | 100 | 35.2 | 42.8 | 41.2 | 0 | 0 |
*Values are percentages. Reference details are provided in the Appendix (https://wwwnc.cdc.gov/EID/26/11/18-1414-App1.pdf). Green indicates a rate of AMR <25%; yellow 25%–50%; red >50%; 25%, and 75% refers to AMR interquartile interval of 25% and 75%. Amp, ampicillin; CFZ, cefazolin; CAX, ceftriaxone, CHL, chloramphenicol; CIP, ciprofloxacin; ERY, erythromycin; IQI, interquartile interval; LZD, linezolid; MXF, moxifloxacin; NA, not applicable; NIT, nitrofurantoin; NT, not tested; PEN, penicillin: TET, tetracycline; TGC, tigecycline; VAN, vancomycin.
Page created: August 17, 2020
Page updated: October 17, 2020
Page reviewed: October 17, 2020
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.